doi: 10.1084/jem.162.3.1099.
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors
- PMID: 2993471
- PMCID: PMC2187809
- DOI: 10.1084/jem.162.3.1099
Item in Clipboard
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors
J Exp Med.
.
Abstract
125I-labeled TNF(LuKII) (tumor necrosis factor) binds specifically to human and mouse cell lines sensitive to the cytotoxic effect of TNF, but not to cells made resistant to TNF. TNF-sensitive cells have cell surface receptors with a high affinity for TNF(LuKII). Mouse TNF competes with TNF(LuKII) for receptor binding. Scatchard analysis of the binding data yielded linear plots and suggests that TNF(LuKII) binds to homogeneous receptor sites. The number of TNF(LuKII) receptors on two TNF-sensitive cell lines is 200-300 per cell and the affinity constant of the receptor for TNF(LuKII) is approximately 1 X 10(-10) M.
Similar articles
-
Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.J Biochem. 1986 Sep;100(3):531-41. doi: 10.1093/oxfordjournals.jbchem.a121744. J Biochem. 1986. PMID: 3023310
-
Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.Proc Natl Acad Sci U S A. 1985 Sep;82(17):5756-60. doi: 10.1073/pnas.82.17.5756. Proc Natl Acad Sci U S A. 1985. PMID: 2994048 Free PMC article.
-
Purification and characterization of a human tumor necrosis factor from the LuKII cell line.Proc Natl Acad Sci U S A. 1985 Oct;82(19):6637-41. doi: 10.1073/pnas.82.19.6637. Proc Natl Acad Sci U S A. 1985. PMID: 3863119 Free PMC article.
-
Demonstration of membrane receptors for human natural and recombinant 125I-labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivity.Eur J Biochem. 1986 Jul 1;158(1):1-5. doi: 10.1111/j.1432-1033.1986.tb09712.x. Eur J Biochem. 1986. PMID: 3015605
-
Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition.J Biol Chem. 1985 Nov 5;260(25):13395-7. J Biol Chem. 1985. PMID: 2997166
Cited by
-
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proc Natl Acad Sci U S A. 1988 Sep;85(18):6875-9. doi: 10.1073/pnas.85.18.6875. Proc Natl Acad Sci U S A. 1988. PMID: 3045826 Free PMC article.
-
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.J Exp Med. 1989 Jun 1;169(6):1977-91. doi: 10.1084/jem.169.6.1977. J Exp Med. 1989. PMID: 2499653 Free PMC article.
-
Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.J Clin Invest. 1986 Dec;78(6):1694-700. doi: 10.1172/JCI112764. J Clin Invest. 1986. PMID: 3023450 Free PMC article.
-
Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.Cancer Immunol Immunother. 1993 Jun;36(6):357-63. doi: 10.1007/BF01742251. Cancer Immunol Immunother. 1993. PMID: 7684652 Free PMC article.
-
Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.Cancer Immunol Immunother. 1992;34(6):399-406. doi: 10.1007/BF01741751. Cancer Immunol Immunother. 1992. PMID: 1563018 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
